The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.
Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile Infection
Open accessAbstract
BACKGROUND & AIMS: Fecal microbiota transplantation (FMT) is a highly effective therapy for recurrent Clostridium difficile infection (CDI). However, transferring undefined living bacteria entails uncontrollable risks for infectious and metabolic or malignant diseases, particularly in immunocompromised patients. We investigated whether sterile fecal filtrates (containing bacterial debris, proteins, antimicrobial compounds, metabolic products, and oligonucleotides/DNA), rather than intact microorganisms, are effective in patients with CDI. METHODS: We performed a clinical case series to investigate the effects of fecal filtrate transfer (FFT) in 5 patients with symptomatic chronic-relapsing CDI at the Department of Internal Medicine I at the University Hospital Schleswig-Holstein (Kiel, Germany). Patients were followed up for at least 6 months and for up to 33 months. Stool was collected from 5 donors selected by the patients, and fully characterized according to FMT standards. Stool was sterile-filtered to remove small particles and bacteria; the filtrate was transferred to patients in a single administration via nasojejunal tube. Fecal samples were collected from patients before and at 1 week and 6 weeks after FFT. Microbiome, virome, and proteome profiles of donors and patients were compared. RESULTS: In all 5 patients, FFT restored normal stool habits and eliminated symptoms of CDI for a minimum period of 6 months. Proteome analyses of selected FFT filtrates showed no obvious protein candidates associated with therapeutic efficacy. 16S ribosomal RNA gene sequencing detected diverse bacterial DNA signatures in the filtrates. Analysis of virus-like particles from a filtrate found to reduce symptoms of CDI showed a complex signature of bacteriophages. Bacterial phylogeny and virome profile analyses of fecal samples from recipients indicated longitudinal changes in microbial and viral community structures after FFT. CONCLUSIONS: A preliminary investigation of 5 patients with CDI shows that transfer of sterile filtrates from donor stool (FFT), rather than fecal microbiota, can be sufficient to restore normal stool habits and eliminate symptoms. This finding indicates that bacterial components, metabolites, or bacteriophages mediate many of the effects of FMT, and that FFT might be an alternative approach, particularly for immunocompromised patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Following successful treatment of C. difficile infection by FFT transplantation, the gut microbiota of a patient with loss of renal function resembled that of the faecal donor with remarkable elimination of Proteobacteria, which had dominated before FFT226.”
From The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease (2018) · cites this paper as [226]
In the citing paper
“The risk of secondary infection may be lower with FFT than with FMT, as FFT does not involve the transfer of live bacteria226.”
From The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease (2018) · cites this paper as [226]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trimmomatic: a flexible trimmer for Illumina sequence data
Bolger, A. M., Lohse, M., & Usadel, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu170 · Cited by 65,548
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 21,481
PAST: PALEONTOLOGICAL STATISTICAL SOFTWARE PACKAGE FOR EDUCATION AND DATA ANALYSIS
Hammer, Ø., Harper, D. A. T., & Ryan, P. D. (2001) · Palaeontologia Electronica · Cited by 17,871
UCHIME improves sensitivity and speed of chimera detection
Edgar, R. C., Haas, B. J., Clemente, J. C., Quince, C., & Knight, R. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr381 · Cited by 15,114
Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms
Caporaso, J. G., Lauber, C. L., Walters, W. A., Berg-Lyons, D., Huntley, J., Fierer, N., Owens, S. M., Betley, J., Fraser, L., Bauer, M., et al. (2012) · The ISME Journal · doi:10.1038/ismej.2012.8 · Cited by 8,839
Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
Ridaura, V. K., Faith, J. J., Rey, F. E., Cheng, J., Duncan, A. E., Kau, A. L., Griffin, N. W., Lombard, V., Henrissat, B., Bain, J. R., et al. (2013) · Science · doi:10.1126/science.1241214 · Cited by 3,788
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
Fadrosh, D. W., Ma, B., Gajer, P., Sengamalay, N., Ott, S., Brotman, R. M., & Ravel, J. (2014) · Microbiome · doi:10.1186/2049-2618-2-6 · Cited by 1,698
Self-citationAssembling Single-Cell Genomes and Mini-Metagenomes From Chimeric MDA Products
Nurk, S., Bankevich, A., Antipov, D., Gurevich, A. A., Korobeynikov, A., Lapidus, A. L., Prjibelski, A. D., Pyshkin, A., Sirotkin, A., Sirotkin, Y., et al. (2013) · Journal of Computational Biology · doi:10.1089/cmb.2013.0084 · Cited by 1,352
Disease-Specific Alterations in the Enteric Virome in Inflammatory Bowel Disease
Norman, J. M., Handley, S. A., Baldridge, M. T., Droit, L., Liu, C. Y., Keller, B. C., Kambal, A., Monaco, C. L., Zhao, G., Fleshner, P., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.002 · Cited by 1,285
Flagged first, then by citations
1 of the 54 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Reyes, 2010, Viruses in the faecal microbiota of monozygotic twins and their mothers, Nature, 466, 334, 10.1038/nature09199 · DOI
Cited by
Sorted by citations
Items 301–400 of 697
Viral metagenomics of the gut virome of diarrheal children with Rotavirus A infection
Bao, S., Wang, H., Li, W., Wu, H., Lu, C., Liang, Y., Zhang, Q., Lü, X., Zhao, M., Lü, J., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2234653 · Cited by 21
Fecal Microbiota Transplantation: Indications, Methods, and Challenges
Lee, J. Y., Kim, Y., Kim, J., & Kim, J. K. (2024) · The Journal of Microbiology · doi:10.1007/s12275-024-00184-3 · Cited by 23
Balancing the risks and rewards of live biotherapeutics
Hill, C. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0254-3 · Cited by 22
Choy, A. M., & Freedberg, D. E. (2020) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284820939447 · Cited by 22
Gut virome dynamics: from commensal to critical player in health and disease
Cárdenas, L. A. C., Leonard, M. M., Baldridge, M. T., & Handley, S. A. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01134-z · Cited by 25
Fecal virome transplantation: A promising strategy for the treatment of metabolic diseases
Zeng, C., Wan, S., Guo, M., Tan, X.-Z., Zeng, Y., Wu, Q., Xie, J.-J., Yan, P., Long, Y., Zheng, L., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117065 · Cited by 24
Fecal virus-like particles are sufficient to reduce necrotizing enterocolitis
Offersen, S. M., Mao, X., Spiegelhauer, M. R., Larsen, F., Li, V. R., Nielsen, D. S., Aunsholt, L., Thymann, T., & Brunse, A. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2392876 · Cited by 22
Majzoub, M. E., Paramsothy, S., Haifer, C., Parthasarathy, R., Borody, T. J., Leong, R. W. L., Kamm, M. A., & Kaakoush, N. O. (2024) · Nature Communications · doi:10.1038/s41467-024-53454-4 · Cited by 24
Gut phages and their interactions with bacterial and mammalian hosts
Godsil, M., Ritz, N. L., Venkatesh, S., & Meeske, A. J. (2025) · Journal of Bacteriology · doi:10.1128/jb.00428-24 · Cited by 22
Diversity, Dynamics and Therapeutic Application of Clostridioides difficile Bacteriophages
Nale, J. Y., Thanki, A. M., Rashid, S. J., Shan, J., Vinner, G. K., Dowah, A. S. A., Cheng, J. K. J., Sicheritz‐Pontén, T., & Clokie, M. R. J. (2022) · Viruses · doi:10.3390/v14122772 · Cited by 19
Feng, H., Xiong, J., Liang, S., Wang, Y., Zhu, Y., Hou, Q., Yang, X., & Yang, X. (2023) · Poultry Science · doi:10.1016/j.psj.2023.103282 · Cited by 19
Current perspectives on fecal microbiota transplantation in inflammatory bowel disease
Singh, A., Midha, V., Chauhan, N. S., & Sood, A. (2024) · Indian Journal of Gastroenterology · doi:10.1007/s12664-023-01516-8 · Cited by 20
Cryopreservation of the human gut microbiota: Current state and perspectives
Smirnova, D. V., Заломова, Л. В., Zagaynova, A. V., Makarov, V. V., Mezhevikina, L. M., Fesenko, E. E., & Yudin, S. M. (2019) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2019.06.001 · Cited by 19
Jukes, C., Ijaz, U. Z., Buckley, A. M., Spencer, J., Irvine, J. J., Candlish, D., Li, J. V., Marchesi, J. R., & Douce, G. R. (2019) · Gut Microbes · doi:10.1080/19490976.2019.1678996 · Cited by 17
The rising dominance of microbiology: what to expect in the next 15 years?
Kumar, R., Sood, U., Kaur, J., Anand, S., Gupta, V., Patil, K. S., & Lal, R. (2021) · Microbial Biotechnology · doi:10.1111/1751-7915.13953 · Cited by 19
Evolution, the Immune System, and the Health Consequences of Socioeconomic Inequality
Rook, G. A. W. (2022) · mSystems · doi:10.1128/msystems.01438-21 · Cited by 21
Fecal microbiota transplantation–early steps on a long journey ahead
Khoruts, A. (2017) · Gut Microbes · doi:10.1080/19490976.2017.1316447 · Cited by 19
Exploring Mucin as Adjunct to Phage Therapy
Carroll‐Portillo, A., & Lin, H. C. (2021) · Microorganisms · doi:10.3390/microorganisms9030509 · Cited by 15
Hot topics on fecal microbiota transplantation for the treatment of inflammatory bowel disease
Zhang, X., Ishikawa, D., Ohkusa, T., Fukuda, S., & Nagahara, A. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1068567 · Cited by 18
Consistent Stool Metagenomic Biomarkers Associated with the Response To Melanoma Immunotherapy
Olekhnovich, E. I., Ivanov, A. B., Babkina, A. A., Sokolov, A. A., Игоревич, У. В., Fedorov, D. E., & Ilina, E. N. (2023) · mSystems · doi:10.1128/msystems.01023-22 · Cited by 17
Fecal microbiota transplantation in the ICU: perspectives on future implementations
Alagna, L., Haak, B. W., & Gori, A. (2019) · Intensive Care Medicine · doi:10.1007/s00134-019-05645-7 · Cited by 18
Browne, P. D., Cold, F., Petersen, A. M., Halkjær, S. I., Christensen, A. H., Günther, S., & Hansen, L. H. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1927635 · Cited by 18
Dietary Effects on the Gut Phageome
Howard, A., Carroll‐Portillo, A., Alcock, J., & Lin, H. C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168690 · Cited by 18
McMurtrie, J., Bell, A. G., Cable, J., Temperton, B., & Tyler, C. R. (2025) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaf027 · Cited by 18
van Lier, Y. F., van den Brink, M. R. M., Hazenberg, M. D., & Markey, K. A. (2021) · Haematologica · doi:10.3324/haematol.2020.270835 · Cited by 18
Li, J., Wang, D., & Sun, J. (2022) · Medicine · doi:10.1097/md.0000000000028584 · Cited by 17
Gut virome in early life: origins and implications
Kennedy, E. A., & Holtz, L. R. (2022) · Current Opinion in Virology · doi:10.1016/j.coviro.2022.101233 · Cited by 18
Varga, A., Makszin, L., Bufa, A., Sipos, D., Kása, P., Pál, S., Rosenstiel, P. C., Sommer, F., Kocsis, B., & Péterfi, Z. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1041384 · Cited by 17
Self-citationHabibi, S., & Rashidi, A. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2229567 · Cited by 17
Stallmach, A., Grunert, P., Stallhofer, J., Löffler, B., Baier, M., Rödel, J., Kiehntopf, M., Neugebauer, S., Pieper, D. H., Junca, H., et al. (2022) · Trials · doi:10.1186/s13063-022-06095-1 · Cited by 17
Yalchin, M., Segal, J. P., Mullish, B. H., Quraishi, M. N., Iqbal, T. H., Marchesi, J. R., & Hart, A. L. (2019) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284819891038 · Cited by 17
Ethical Considerations in Microbial Therapeutic Clinical Trials
Woodworth, M. H., Sitchenko, K. L., Carpentieri, C., Friedman‐Moraco, R., Wang, T. L., & Kraft, C. S. (2017) · The New Bioethics · doi:10.1080/20502877.2017.1387386 · Cited by 16
Fernández, L., Duarte, A. C., Rodrı́guez, A., & García, P. (2021) · Beneficial Microbes · doi:10.3920/bm2020.0132 · Cited by 18
Boicean, A., Bratu, D. G., Fleacă, R. S., Vasile, G., Shelly, L., Bîrsan, S., Bacila, C. I., & Hasegan, A. G. (2023) · Pathogens · doi:10.3390/pathogens12091149 · Cited by 16
Nasal microbiota transplantation: a gateway to novel treatments
Shekhar, S., Schwarzer, M., Dhariwal, A., & Petersen, F. C. (2025) · Trends in Microbiology · doi:10.1016/j.tim.2024.12.010 · Cited by 16
Evolving Strategies to Manage Clostridium difficile Colitis
Bowman, J. A., & Utter, G. H. (2019) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-019-04478-5 · Cited by 16
Gotoh, K., Sakaguchi, Y. M., Kato, H., Osaki, H., Jodai, Y., Wakuda, M., Take, A., Hayashi, S., Morita, E., 杉江, 岳., et al. (2021) · Anaerobe · doi:10.1016/j.anaerobe.2021.102502 · Cited by 16
Capsules for Fecal Microbiota Transplantation in Recurrent Clostridium difficile Infection
Rao, K. K., Young, V. B., & Malani, P. (2017) · JAMA · doi:10.1001/jama.2017.17969 · Cited by 16
Ji, S., Ahmad, F., Peng, B.-Z., Yang, Y., Su, M., Zhao, X.-S., & Vatanen, T. (2025) · Microbiome · doi:10.1186/s40168-025-02046-5 · Cited by 17
Kao, D. H., Wong, K., Lee, C., Steiner, T. S., Franz, R., McDougall, C., Silva, M., Schmidt, T., Walter, J., Löebenberg, R., et al. (2025) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(25)00190-6 · Cited by 15
Baaziz, H., Baker, Z. R., Franklin, H. C., & Hsu, B. B. (2022) · iScience · doi:10.1016/j.isci.2022.104146 · Cited by 18
The gut virome in health and disease: new insights and associations
Shareefdeen, H., & Hill, C. (2022) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000885 · Cited by 15
Icho, S., Ward, J. S., Tam, J., Kociolek, L. K., Theriot, C. M., & Melnyk, R. A. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2301252120 · Cited by 15
Bioinformatic Methodologies in Assessing Gut Microbiota
Fox, J. D., Sims, A., Ross, M., Bettag, J., Wilder, A., Natrop, D., Borsotti, A., Kolli, S., Mehta, S., Verma, H., et al. (2024) · Microbiology Research · doi:10.3390/microbiolres15040170 · Cited by 15
Genetically Engineered Bacteria for Treating Human Disease
Ma, B., Pan, Q., & Peppelenbosch, M. P. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.07.001 · Cited by 16
Our Microbiome: On the Challenges, Promises, and Hype
Federici, S., Suez, J., & Elinav, E. (2020) · Results and problems in cell differentiation · doi:10.1007/978-3-030-51849-3_20 · Cited by 15
Microbial evolutionary medicine: from theory to clinical practice
Andersen, S. B., Shapiro, B. J., Vandenbroucke‐Grauls, C. M. J. E., & de Vos, M. G. J. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30045-3 · Cited by 15
Alaeddin, S., Chatterjee, A., Roberts, T. L., Steiner-Lim, G. Z., Jensen, S. O., Gyengési, E., Muench, G. W., & Ho, V. (2025) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2025.101049 · Cited by 17
Isidro, J., Mendes, A. L., Serrano, M., Henriques, A. O., & Oleastro, M. (2017) · InTech eBooks · doi:10.5772/intechopen.69053 · Cited by 13
Mochochoko, B. M., Pohl, C. H., & O’Neill, H. G. (2022) · iScience · doi:10.1016/j.isci.2022.105870 · Cited by 14
Transplantation of fecal filtrate to neonatal pigs reduces post-weaning diarrhea: A pilot study
Larsen, C., Andersen, A. B., Sato, H., Brunse, A., & Thymann, T. (2023) · Frontiers in Veterinary Science · doi:10.3389/fvets.2023.1110128 · Cited by 14
Aitken, J. M., Aitken, J., & Agrawal, G. K. (2024) · Antibiotics · doi:10.3390/antibiotics13020158 · Cited by 14
Yang, Z., Yang, M., Deehan, E. C., Cai, C., Madsen, K. L., Wine, E., Li, G., Li, J., Liu, J., & Zhang, Z. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2387796 · Cited by 17
Combatting Antibiotic Resistance: Leveraging Fecal Microbial Transplantation for Gut Health
Upreti, P., Devhare, L., Abdulmageed, L. H., Kumar, Y. G., Kumar, R., & Dharmamoorthy, G. (2024) · Springer eBooks · doi:10.1007/978-981-97-5272-0_10 · Cited by 13
Selected Mechanisms of Action of Bacteriophages in Bacterial Infections in Animals
Urban‐Chmiel, R., & Pyzik, E. (2025) · Viruses · doi:10.3390/v17010101 · Cited by 16
Therapeutic implications of the gastrointestinal microbiome
Kashyap, P., & Quigley, E. M. M. (2018) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2018.01.004 · Cited by 15
What is unknown in using microbiota as a therapeutic?
Sung, J. J. �., & Wong, S. H. (2021) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15716 · Cited by 14
Methods of DNA introduction for the engineering of commensal microbes
Liu, D., Siguenza, N., Zarrinpar, A., & Ding, Y. (2022) · Engineering Microbiology · doi:10.1016/j.engmic.2022.100048 · Cited by 16
The gut microbiota: cause and cure of gut diseases
White, L. S., van den Bogaerde, J., & Kamm, M. A. (2018) · The Medical Journal of Australia · doi:10.5694/mja17.01067 · Cited by 14
Is there a role for microbiome-based approach in common variable immunodeficiency?
Poto, R., Ianiro, G., de Paulis, A., Spadaro, G., Marone, G., Gasbarrini, A., & Varricchi, G. (2023) · Clinical and Experimental Medicine · doi:10.1007/s10238-023-01006-3 · Cited by 16
Standards for fecal microbiota transplant: Tools and therapeutic advances
Belotserkovsky, I., Stabryla, L. M., Hunter, M. E., Allegretti, J. R., Callahan, B. J., Carlson, P. E., Daschner, P. J., Goudarzi, M., Guyard, C., Jackson, S. A., et al. (2024) · Biologicals · doi:10.1016/j.biologicals.2024.101758 · Cited by 13
Clostridioides difficile infection in inflammatory bowel disease: a clinical review
Tang, M., Wang, C., Xia, Y., Tang, J., Wang, J., & Shen, L. (2024) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2024.2347955 · Cited by 14
Kaden, T., Alonso‐Román, R., Stallhofer, J., Gresnigt, M. S., Hube, B., & Mosig, A. S. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202402756 · Cited by 13
Tholey, A., Taylor, N. L., Heazlewood, J. L., & Bendixen, E. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00408 · Cited by 13
Self-citationFairhurst, N. G., & Travis, S. P. L. (2018) · Intestinal Research · doi:10.5217/ir.2018.16.2.209 · Cited by 13
Gut virome dysbiosis following focal cerebral ischemia in mice
Chelluboina, B., Kieft, K., Breister, A. M., Anantharaman, K., & Vemuganti, R. (2022) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x221107702 · Cited by 13
Novel technologies to characterize and engineer the microbiome in inflammatory bowel disease
Boix-Amorós, A., Monaco, H., Sambataro, E., & Clemente, J. C. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2107866 · Cited by 13
Bai, T., Zhang, L., Wang, H., Qian, W., Song, J., & Hou, X. (2018) · BioMed Research International · doi:10.1155/2018/3860743 · Cited by 13
Faecal microbiota transplantation in Australia: bogged down in regulatory uncertainty
Costello, S. P., & Bryant, R. V. (2019) · Internal Medicine Journal · doi:10.1111/imj.14212 · Cited by 12
Zhang, Y., Wu, Y., Zhao, X., Ye, Q., Cao, L., Liu, M., Gao, B., Niu, Q., Chen, N., Duan, Z., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.07.028 · Cited by 12
How Can Nutrition Help with Gastrointestinal Tract–Based Issues?
Hesta, M., & Costa, M. (2021) · Veterinary Clinics of North America Equine Practice · doi:10.1016/j.cveq.2020.12.007 · Cited by 16
Microbiome therapeutics for the treatment of recurrent Clostridioides difficile infection
Bloom, P. P., & Young, V. B. (2022) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2022.2154600 · Cited by 12
Role of bacteria and microbial metabolites in immune modulation during early life
Oldereid, T. S., Jiang, X., Nordhus, K. S., Ponzetta, A., Bjørnholt, J. V., Björkström, N. K., Melum, E., & Rasmussen, H. (2023) · Scandinavian Journal of Immunology · doi:10.1111/sji.13336 · Cited by 12
Rook, G. A. W. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105653 · Cited by 12
Prevention and treatment of recurrent Clostridioides difficile infection
Shin, J. H., & Warren, C. A. (2019) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000587 · Cited by 12
STRUCTURING A FECAL MICROBIOTA TRANSPLANTATION CENTER IN A UNIVERSITY HOSPITAL IN BRAZIL
Terra, D., Vilela, E. G., Silva, R. O. S., LEÃO, L. A., Karine Sampaio, L. I. M. A., PASSOS, R. I. F. Â., Diniz, A. N., & Coelho, L. G. V. (2020) · Arquivos de Gastroenterologia · doi:10.1590/s0004-2803.202000000-79 · Cited by 11
Rakotonirina, A., Galperine, T. K., & Allémann, É. (2022) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2022.2095901 · Cited by 14
Inulin reduces liver triacylglycerol by increasing lipid droplet lipolysis in fat-loaded mice
Chen, B., Shi, Y., Zhang, K., Chang, Y., Fu, P., Liu, P., & Zhang, S. (2022) · Food Research International · doi:10.1016/j.foodres.2022.112226 · Cited by 12
Wu, D., Zhang, C., Liu, Y., Yao, J., Yang, X., Wu, S., Du, J., & Yang, X. (2023) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2023.02.005 · Cited by 14
Malik, A., & Malik, M. I. (2023) · Gastroenterology Research · doi:10.14740/gr1624 · Cited by 12
Dicks, L. M. T. (2023) · Microorganisms · doi:10.3390/microorganisms11092161 · Cited by 12
Fecal Microbiota Therapy With a Focus on Clostridium difficile Infection
Brandt, L. J. (2017) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000511 · Cited by 12
Exploring the virome: An integral part of human health and disease
Gholamzad, A., Khakpour, N., Hashemi, S. M. A., Goudarzi, Y., Ahmadi, P., Gholamzad, M., Mohammadi, M., & Gholamzad, M. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155466 · Cited by 13
Bacteriophages: a double-edged sword in the gastrointestinal tract
Wei, Y., & Zhou, C. (2024) · Frontiers in Microbiomes · doi:10.3389/frmbi.2024.1450523 · Cited by 13
Rubin, Z., Martin, E. M., & Allyn, P. R. (2018) · Current Infectious Disease Reports · doi:10.1007/s11908-018-0639-4 · Cited by 11
Intestinal immune response is regulated by gut microbe
Tanemoto, S., Sujino, T., & Kanai∥, T. (2017) · Japanese Journal of Clinical Immunology · doi:10.2177/jsci.40.408 · Cited by 11
The Russian Doll Model: How Bacteria Shape Successful and Sustainable Inter-Kingdom Relationships
Pessione, E. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.573759 · Cited by 11
Viruses, cancer and non-self recognition
Padariya, M., Kalathiya, U., Mikac, S., Dziubek, K., Tovar-Fernandez, M. C., Sroka, E. M., Fåhræus, R., & Sznarkowska, A. (2021) · Open Biology · doi:10.1098/rsob.200348 · Cited by 13
Wang, X., Li, J., Ge, Z., Fan, J., Ma, D., Cao, H., Shen, J., Wang, Y., Liu, Z., Gomaa, S. E., et al. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1672198 · Cited by 10
Wang, Z., Dai, Y., Azi, F., Dong, M., & Xia, X. (2024) · Antioxidants · doi:10.3390/antiox13030259 · Cited by 10
The emerging role of the gut virome in necrotizing enterocolitis
Yi, C., Chen, J., & She, X. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e30496 · Cited by 10
Perspective: on the future of fecal microbiota transplantation
Larsen, O. F. A., & Brummer, R. J. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1449133 · Cited by 10
Precision microbial regulation: Strategies for modulating GIT microbiota for host health
Pei, Z., Li, Q., Zhang, Y., Guo, C., Abdelsattar, M. M., & Bi, Y. (2025) · iMetaOmics. · doi:10.1002/imo2.54 · Cited by 12
Pauer, H., Teixeira, F. L., Robinson, A. V., Parente, T. E., de Melo, M. A. F., Lobo, L. A., Domingues, R. M. C. P., Allen‐Vercoe, E., Ferreira, R. B. R., & Antunes, L. C. M. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1918993 · Cited by 10
Global trends in gut microbiota and clostridioides difficile infection research: A visualized study
Li, Z., Ke, H., Lin, Q., Shen, Z., & Chen, Y. (2022) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2022.06.011 · Cited by 10
“Phage Transplantation in Allotransplantation”: Possible Treatment in Graft-Versus-Host Disease?
Górski, A., Jończyk‐Matysiak, E., Międzybrodzki, R., Weber‐Dąbrowska, B., & Borysowski, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00941 · Cited by 10
Considering the Other Half of the Gut Microbiome: Bacteriophages
Maurice, C. F. (2019) · mSystems · doi:10.1128/msystems.00102-19 · Cited by 10
Zhang, Z., Zhu, T., Li, Y., Yu, B., Tao, H., Zhao, H., & Cui, B. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c07966 · Cited by 11
Impact of prophages on gut microbiota and disease associations
Mahmoud, A. A., Wang, X., Liao, X., Zhang, S., Ding, T., & Ahn, J. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.107642 · Cited by 9
Carasso, S., Keshet-David, R., Zhang, J., Hajjo, H., Kadosh-Kariti, D., Gefen, T., & Geva‐Zatorsky, N. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2501492 · Cited by 9
Metadata
- Authors
- Ott, S. J., Waetzig, G. H., Rehman, A., Moltzau-Anderson, J., Bharti, R., Grasis, J. A., Cassidy, L., Tholey, A., Fickenscher, H., Seegert, D., Rosenstiel, P., & Schreiber, S.
- Affiliations
- University Hospital Schleswig-Holstein (DE)
- Conaris (DE)
- Christian-Albrechts-Universität zu Kiel (DE)
- San Diego State University (US)
- Corresponding author
- Schreiber, Stefan
- ORCID
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2017-03
- Volume
- 152
- Issue
- 4
- Pages
- 799-811.e7
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2550586225
- Cited by
- 695
- References
- 54
- Citations by year
- 2026: 37 · 2025: 64 · 2024: 83 · 2023: 73 · 2022: 85 · 2021: 96 · 2020: 65 · 2019: 82 · 2018: 69 · 2017: 38
- FWCI
- 58.44
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Gastroenterology (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion, cc-by-nc-nd)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (CRC 1182)
- Exzellenzclusters Entzündungsforschung
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- fecal microbiota transplantation, Clostridium difficile infection, recurrent Clostridium difficile infection, sterile filtration, bacteriophages, virome, microbiome, immunocompromised patients, bacterial community structure
- MeSH terms
- Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Aged, Enterocolitis, Pseudomembranous, Female, Filtration, Humans, Male, Middle Aged, Recurrence, Sterilization, Clostridioides difficile, Proteome, Gastrointestinal Tract
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review